Gossamer Bio is trading at $9.99, up 6.05%, amid stronger biotech and broader-market sentiment; no clear company-specific announcement explaining the move was found.
- At 1:37 p.m. EST on November 6, 2026.
- Moderna reported a quarterly profit and raised its 2026 revenue-growth outlook, helping lift sector sentiment.
- Broader markets were also higher, including the Nasdaq.